We speculated that although MT2 is expressed at a low level in human beings [50]; its abnormal expression in AIS patients might directly affect the melatonin signaling pathway and, hence, the physiological modulating effect of melatonin. Here, MTNR1B is linked to androgen insensitivity syndrome.